Biology of Blood and Marrow Transplantation
Volume 13, Issue 7 , Pages 871-872 , July 2007

Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV?

References 

  1. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant. 2002;29:691–698
  2. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 1998;11:569–588
  3. Lim Z, Baker B, Zuckermann M, et al. Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation. J Infect. 2007;54:e83–e86
  4. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients (Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation). Cytotherapy. 2001;3:41–54
  5. Martino R, Bretagne S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation (Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation). Bone Marrow Transplant. 2000;25:1111–1114
  6. Masur H, Kaplan JE, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons—2002 (Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America). Ann Intern Med. 2002;137(5 Pt 2):435–478

PII: S1083-8791(07)00218-2

doi: 10.1016/j.bbmt.2007.03.010

Biology of Blood and Marrow Transplantation
Volume 13, Issue 7 , Pages 871-872 , July 2007

Article Tools

* Image Usage & Resolution